Abstract
NGR-peptide-conjugated polymeric liposome, NGR/liposome/PEI/ODN (NGR/LPD), was prepared with oligodeoxynucleotide (ODN) condensed with PEI at a N/P ratio of 10:1 and PEG-stabilized liposome composed of 94% POPC, 2% DDAB, 3% DSPEPEG- 2000 and 1% DSPE-PEG-2000-maleimide. Liposome/PEI/ODN (LPD) complexes could significantly reduce toxicity of PEI and also enhance uptake of ODN by MCF-7 breast cancer cells compared with naked ODN. It was found that the differences in apoptosis index between NGR/LPD and LPD group were significant (P < 0.05). Tumor tissue showed necrosis in high dose group of NGR/LPD (20 µ g ASODN). In comparison with control group, the levels of hTERT mRNA, hTERT protein as well as c-Myc protein in the NGR/LPD group were markedly lower (P < 0.05) and the level of Bcl-2 protein in the NGR/LPD group was significantly higher (P < 0.05). NGR/LPD had the function of targeting to tumor cells compared with LPD and could inhibit tumor cells growth compared with control group.
Keywords: Oligodeoxynucleotide Acid, NGR, In Vitro, In Vivo, PEI, tumor cells, NGR/liposome/PEI/ODN, hTERT, Liposome/PEI/ODN, breast cancer cells, c-Myc, Tumor target, gene therapy, LPD
Current Nanoscience
Title: Oligodeoxynucleotide Acid Loaded, NGR-Peptide-Conjugated Polymeric Liposomes: In Vitro and In Vivo Evaluation
Volume: 7 Issue: 5
Author(s): Huixiang Li, Yanjiang Shao, Xiaojuan Wang, Songxia Quan, Yingge Zhang and Zhenzhong Zhang
Affiliation:
Keywords: Oligodeoxynucleotide Acid, NGR, In Vitro, In Vivo, PEI, tumor cells, NGR/liposome/PEI/ODN, hTERT, Liposome/PEI/ODN, breast cancer cells, c-Myc, Tumor target, gene therapy, LPD
Abstract: NGR-peptide-conjugated polymeric liposome, NGR/liposome/PEI/ODN (NGR/LPD), was prepared with oligodeoxynucleotide (ODN) condensed with PEI at a N/P ratio of 10:1 and PEG-stabilized liposome composed of 94% POPC, 2% DDAB, 3% DSPEPEG- 2000 and 1% DSPE-PEG-2000-maleimide. Liposome/PEI/ODN (LPD) complexes could significantly reduce toxicity of PEI and also enhance uptake of ODN by MCF-7 breast cancer cells compared with naked ODN. It was found that the differences in apoptosis index between NGR/LPD and LPD group were significant (P < 0.05). Tumor tissue showed necrosis in high dose group of NGR/LPD (20 µ g ASODN). In comparison with control group, the levels of hTERT mRNA, hTERT protein as well as c-Myc protein in the NGR/LPD group were markedly lower (P < 0.05) and the level of Bcl-2 protein in the NGR/LPD group was significantly higher (P < 0.05). NGR/LPD had the function of targeting to tumor cells compared with LPD and could inhibit tumor cells growth compared with control group.
Export Options
About this article
Cite this article as:
Li Huixiang, Shao Yanjiang, Wang Xiaojuan, Quan Songxia, Zhang Yingge and Zhang Zhenzhong, Oligodeoxynucleotide Acid Loaded, NGR-Peptide-Conjugated Polymeric Liposomes: In Vitro and In Vivo Evaluation, Current Nanoscience 2011; 7 (5) . https://dx.doi.org/10.2174/157341311797483880
DOI https://dx.doi.org/10.2174/157341311797483880 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |
Call for Papers in Thematic Issues
Role of nanomaterials in fabrication of coatings, Machining and Joining
The application of nanoscience has brought about a revolution in the field of mechanical engineering by providing novel materials, boosting manufacturing processes, and generating cutting-edge products. The purpose of this special issue is to investigate the enormous impact that nanoscience has had on mechanical engineering, with a particular emphasis on ...read more
Advanced Inorganic Nanocomposites and Their Emerging Applications
This special issue collection will highlight developments on the recent trends about the synthesis of metal oxides, nanoclusters, biomaterials, 2D nanomaterials, nanocrystals, nanocomposites, etc. and their applications in electrochemical systems, tissue regeneration, energy storage and harvesting, sensors, etc. The novelty of the methods in the chemical synthesis and their characterizations, ...read more
Applicability of Nanotechnology for Performance Enhancement of Clean Energy Technologies
Population growth, industrialization, and improvement in living quality would lead to further increase in energy demand in near future. Regarding the disadvantages of fossil fuels such as fluctuations in their price, high emissions of greenhouse gases and restriction of their sources, it is crucial to use and exploit alternative energy ...read more
Graphene and 2D Materials for Energy Storage and Conversion
This thematic issue will discuss the recent advances in graphene-based nanomaterials for different energy technologies. Graphene possesses a high surface area, and stable structure and exhibits many interesting electronic, optical, and mechanical properties due to its 2D crystal structure. Graphene is of both fundamental interest and suitable for a wide ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
BRCA1-Associated Triple-Negative Breast Cancer and Potential Treatment for Ruthenium-Based Compounds
Current Cancer Drug Targets Functional Role of Glycosphingolipids in Cancer
Current Medicinal Chemistry Aflibercept (VEGF-TRAP): The Next Anti-VEGF Drug
Inflammation & Allergy - Drug Targets (Discontinued) Oncolytic HSV-1 Virotherapy: Clinical Experience and Opportunities for Progress
Current Pharmaceutical Biotechnology Gallium in Cancer Treatment
Current Topics in Medicinal Chemistry An Overview on Fibroblast Growth Factors: Structural, Functional and Therapeutic Implications
Current Proteomics Macrophage-Assisted Inflammation and Pharmacological Regulation of the Cholinergic Anti-Inflammatory Pathway
Current Medicinal Chemistry Resveratrol as an Adjuvant for Normal Tissues Protection and Tumor Sensitization
Current Cancer Drug Targets Suppression of HIV-1 Viral Replication by Inhibiting Drug Efflux Transporters in Activated Macrophages
Current HIV Research Somatostatin and its Analogs
Current Drug Targets Anti-Angiogenic Effects of Resveratrol on Cerebral Angiogenesis
Current Neurovascular Research Targeting Indoleamine 2,3-dioxygenase (IDO) to Counteract Tumour- Induced ImmuneDysfunction: From Biochemistry to Clinical Development
Endocrine, Metabolic & Immune Disorders - Drug Targets Synergistic Antiproliferative and Antiangiogenic Effects of EGFR and mTOR Inhibitors
Current Pharmaceutical Design Editorial [Hot topic: Breast Cancer: Novel Therapeutic Targets (Guest Editor: George W. Yip)]
Recent Patents on Anti-Cancer Drug Discovery Stimuli-Responsive Nanoparticles for siRNA Delivery
Current Pharmaceutical Design Targeting Angiogenesis in Ovarian Carcinoma
Current Cancer Therapy Reviews Antimicrobial Resistance in the 21st Century: A Multifaceted Challenge
Protein & Peptide Letters Genetics of Cancer Susceptibility
Current Genomics Biodistribution and Pharmacokinetics of I-131 Labelled 4- Iodophenylacetic Acid
Current Radiopharmaceuticals Severe Adenovirus Pneumonia Followed by Bacterial Septicaemia: Relevance of Co-Infections in Allogeneic Hematopoietic Stem Cell Transplantation
Infectious Disorders - Drug Targets